Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy

Fig. 2

Symptom severity assessed at Visit 1 and 2 following the two weeks treatment period; mean ± 95% CI; Significant differences are marked by stars, *: p < 0.01, **: p < 0.001, ***: p < 0.0001; N = 42.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us